Chemerin as a marker of subclinical cardiac involvement in psoriatic patients


Creative Commons License

Aksu F., ÇALIŞKAN M. , Keles N., Toprak A. E. , Uzuncakmak T. K. , Kostek O., ...More

CARDIOLOGY JOURNAL, vol.24, no.3, pp.276-283, 2017 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Article
  • Volume: 24 Issue: 3
  • Publication Date: 2017
  • Doi Number: 10.5603/cj.a2017.0031
  • Title of Journal : CARDIOLOGY JOURNAL
  • Page Numbers: pp.276-283
  • Keywords: chemerin, flow-mediated dilatation, epicardial fat tissue, psoriasis, C-REACTIVE PROTEIN, ENDOTHELIAL FUNCTION, CARDIOVASCULAR RISK, METABOLIC SYNDROME, ATHEROSCLEROSIS, DYSFUNCTION, FAT, INFLAMMATION, ASSOCIATION, DISEASE

Abstract

Background: Chemerin has been associated with psoriasis and inflammation, but there are no studies demonstrating an association between chemerin and subclinical cardiac involvement in psoriatic patients. Therefore, the present study aimed to evaluate whether psoriatic patients with increased epicardial fat tissue, impaired flow-mediated dilatation, and diastolic dysfunction have higher serum chemerin levels than a healthy control group.